Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.
Boston
Operating Cash Flow
=
EBITDA
-
Taxes
=
1.21 B
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about company having enough liquid resources to meet current and long term debt obligations.
In accordance with recently published financial statements Boston Scientific Corporation has 1.21 B in Cash Flow from Operations. This is 175.34% higher than that of Healthcare sector, and 249.01% higher than that of Medical Appliances and Equipment industry, The Cash Flow from Operations for all stocks is 117.05% lower than the firm.
Filter other Stocks by Cash Flow from Operations
Specify Market Cap
Select Cash Flow from Operations Range
Current Range
Indicate Industry
Click to run this filter
Filter Other Equities
Cash Flow from Operations Comparison
Boston is rated fifth in cash flow from operations category among related companies.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
NYSE Boston Scientific Corporation
-0.11%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
